Compare HLLY & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HLLY | SGHT |
|---|---|---|
| Founded | 1903 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 363.7M | 309.6M |
| IPO Year | 2020 | 2021 |
| Metric | HLLY | SGHT |
|---|---|---|
| Price | $3.01 | $8.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | $4.83 | ★ $9.08 |
| AVG Volume (30 Days) | ★ 904.2K | 221.0K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 180.00 | 28.16 |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $613,514,000.00 | $77,363,000.00 |
| Revenue This Year | $6.32 | $11.67 |
| Revenue Next Year | $4.98 | $10.39 |
| P/E Ratio | $76.25 | ★ N/A |
| Revenue Growth | ★ 1.87 | N/A |
| 52 Week Low | $2.33 | $3.19 |
| 52 Week High | $4.48 | $9.24 |
| Indicator | HLLY | SGHT |
|---|---|---|
| Relative Strength Index (RSI) | 55.45 | 66.08 |
| Support Level | $2.42 | $8.00 |
| Resistance Level | $3.25 | $8.80 |
| Average True Range (ATR) | 0.11 | 0.33 |
| MACD | -0.01 | -0.11 |
| Stochastic Oscillator | 60.00 | 52.33 |
Holley Inc designs, manufactures, and distributes high-performance automotive aftermarket products to car and truck enthusiasts in the United States, Canada and Europe. It manufactures a diversified line of performance automotive products, including carburetors, fuel pumps, fuel injection systems, nitrous oxide injection systems, superchargers, exhaust headers, mufflers, distributors, ignition components, engine tuners and automotive performance plumbing products. It also manufactures exhaust products as well as shifters, converters, transmission kits, transmissions, tuners and automotive software. The company markets its products under brands such as Holley, Holley EFI, MSD, Simpson, Flowmaster, EDGE, Cataclean, and Accel, among others. It operates in single segment.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.